John Strouse/LinkedIn
Aug 14, 2026, 15:50
John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
John Strouse, Associate Professor of Medicine at Duke University Medical Center, shared a post on LinkedIn:
”We need to include and encourage older adult with SCD to partipate in clinical trials of new treatments for Sickle cell disease.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology